Alimera Sciences, Inc. (ALIM) Social Stream
Alimera Sciences Inc (ALIM) Price Targets From Analysts
Use the tables below to see what analysts covering Alimera Sciences Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 3 | $18 | $12 | $14.83 | $4.69 | 216.2% |
The Trend in the Analyst Price Target
ALIM's average price target has moved up $0.58 over the prior 170 days.
ALIM reports an average of 110.26% for its upside potential over the past 16 months.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-09-20 | 3 | 18 | 12 | 14.83 | 4.59 | 223.09% |
| 2021-09-19 | 3 | 18 | 12 | 14.83 | 4.86 | 205.14% |
| 2021-09-18 | 3 | 18 | 12 | 14.83 | 4.86 | 205.14% |
| 2021-09-11 | 4 | 18 | 12 | 14.88 | 5.57 | 167.15% |
| 2021-09-04 | 4 | 18 | 12 | 14.88 | 6.02 | 147.18% |
| 2021-08-28 | 4 | 18 | 12 | 14.88 | 6.52 | 128.22% |
| 2021-08-14 | 4 | 18 | 15 | 16.38 | 7.31 | 124.08% |
| 2021-08-07 | 4 | 18 | 15 | 16.38 | 8.12 | 101.72% |
| 2021-08-05 | 4 | 18 | 15 | 16.38 | 8.59 | 90.69% |
| 2021-08-01 | 4 | 18 | 15 | 16.38 | 8.83 | 85.5% |
| 2021-07-24 | 4 | 18 | 15 | 16.38 | 8.91 | 83.84% |
| 2021-07-17 | 4 | 18 | 15 | 16.38 | 8.82 | 85.71% |
| 2021-07-10 | 4 | 18 | 15 | 16.38 | 9.18 | 78.43% |
| 2021-07-03 | 4 | 18 | 15 | 16.38 | 9.02 | 81.6% |
| 2021-06-26 | 4 | 18 | 15 | 16.38 | 9.50 | 72.42% |
| 2021-06-13 | 4 | 18 | 15 | 16.38 | 10.30 | 59.03% |
| 2021-06-05 | 4 | 18 | 15 | 16.38 | 10.28 | 59.34% |
| 2021-05-22 | 4 | 18 | 15 | 16.38 | 9.80 | 67.14% |
| 2021-05-15 | 4 | 18 | 15 | 16.38 | 8.57 | 91.13% |
| 2021-05-08 | 4 | 18 | 15 | 16.38 | 9.67 | 69.39% |
| 2021-04-25 | 4 | 18 | 14 | 15.88 | 10.70 | 48.41% |
| 2021-04-17 | 4 | 18 | 14 | 15.88 | 9.80 | 62.04% |
| 2021-04-10 | 4 | 18 | 10 | 14.25 | 9.56 | 49.06% |
| 2021-04-03 | 4 | 18 | 10 | 14.25 | 9.86 | 44.52% |
| 2021-03-20 | 4 | 18 | 10 | 14.25 | 11.10 | 28.38% |
| 2021-03-13 | 4 | 18 | 10 | 14.25 | 11.29 | 26.22% |
| 2021-03-06 | 4 | 18 | 10 | 14.25 | 7.32 | 94.67% |
| 2021-02-27 | 4 | 18 | 10 | 14.25 | 8.07 | 76.58% |
| 2021-02-20 | 4 | 18 | 10 | 13.50 | 9.20 | 46.74% |
| 2021-02-13 | 4 | 18 | 10 | 13.50 | 8.50 | 58.82% |
| 2021-02-06 | 4 | 18 | 10 | 13.50 | 7.91 | 70.67% |
| 2021-01-30 | 4 | 18 | 10 | 13.50 | 6.72 | 100.89% |
| 2021-01-23 | 4 | 18 | 10 | 13.50 | 8.00 | 68.75% |
| 2021-01-16 | 4 | 18 | 10 | 13.50 | 6.60 | 104.55% |
| 2021-01-09 | 4 | 18 | 10 | 13.50 | 5.80 | 132.76% |
| 2021-01-02 | 4 | 18 | 10 | 13.50 | 4.22 | 219.91% |
| 2020-12-26 | 4 | 18 | 10 | 13.50 | 4.43 | 204.74% |
| 2020-12-19 | 4 | 18 | 10 | 13.50 | 4.19 | 222.2% |
| 2020-12-09 | 4 | 18 | 10 | 13.50 | 4.18 | 222.97% |
| 2020-12-07 | 4 | 18 | 10 | 13.50 | 4.15 | 225.3% |
| 2020-11-28 | 4 | 18 | 10 | 13.50 | 4.71 | 186.62% |
| 2020-09-30 | 4 | 18 | 10 | 13.50 | NA | NA% |
| 2020-08-17 | 4 | 18 | 10 | 13.50 | NA | NA% |
| 2020-07-23 | 3 | 18 | 12 | 14.67 | NA | NA% |
| 2020-06-27 | 4 | 18 | 12 | 14.75 | NA | NA% |
| 2020-06-20 | 4 | 18 | 12 | 14.75 | NA | NA% |
| 2020-05-23 | 5 | 18 | 12 | 15.34 | NA | NA% |
ALIM Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 0 | 3 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
ALIM's average broker recommendation rating improved by 0 over the prior 30 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- Alimera Sciences Inc's upside potential (average analyst target price relative to current price) is greater than 90.26% of all US stocks.
- The number of analysts covering the stock of ALIM is greater than 23.39% of Pharmaceutical Products stocks.
- The variance in analysts' estimates of ALIM is lower than 28% of stocks in the small market cap category.
- ALIM has a greater average analyst price target than 28.26% of all US stocks.
Stocks similar to Alimera Sciences Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TFFP, OTLK and ENTX.
Make investment decisions regarding ALIM using the data that counts. Try POWR Ratings for free.